Skip to main content
. 2018 Dec 17;80(5):540–546. doi: 10.1055/s-0038-1676628

Fig. 4.

Fig. 4

Kaplan–Meier plot demonstrates freedom from volumetric progression for tumors while off bevacizumab (dashed line) and during bevacizumab treatment (solid line). Cox regression demonstrated a significant reduction in volumetric progression with bevacizumab treatment.